First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant
详细信息 查看全文
- 作者：Rosa Burdi ; Maria Paola Didonna ; Bernadette Pignol ; Beatrice Nico ; Domenica Mangieri ; Jean-Franç ; ois Rolland ; Claudia Camerino ; Alberta Zallone ; Paolo Ferro ; Francesca Andreetta et al.
- 关键词：Calpains inhibition ; Antioxidant activity ; Hybrid compounds ; Skeletal muscle ; Muscular dystrophy ; Mdx mice ; Strength ; Functional parameters ; Creatine kinase ; Markers of fibrosis
- 刊名：Neuromuscular Disorders
- 出版年：2006
- 出版时间：April 2006
- 年：2006
- 卷：16
- 期：4
- 页码：237-248
- 全文大小：384 K
文摘
BN 82270 is a membrane-permeable prodrug of a chimeric compound (BN 82204) dually acting as calpain inhibitor and anti-oxidant. Acute in vivo injection of dystrophic mdx mice (30 mg/kg, s.c.) fully counteracted calpain overactivity in diaphragm. A chronic 4–6 weeks administration significantly prevented in vivo the fore limb force drop occurring in mdx mice exercised on treadmill. Ex vivo electrophysiological recordings showed that BN 82270 treatment contrasted the decrease in chloride channel function (gCl) in diaphragm, an index of spontaneous degeneration, while it was less effective on both exercise-impaired gCl and calcium-dependent mechanical threshold of the hind limb extensor digitorum longus (EDL) muscle fibres. The BN 82270 treated mdx mice showed a marked reduction of plasma creatine kinase and of the pro-fibrotic cytokine TGF-β1 in both hind limb muscles and diaphragm; however, the histopathological profile of gastrocnemious muscle was poorly ameliorated. In hind limb muscles of treated mice, the active form was detected by HPLC in the low therapeutic concentration range. In vitro exposure to 100 μM BN 82270 led to higher active form in diaphragm than in EDL muscle. This is the first demonstration that this class of chimeric compounds, dually targeting pathology-related events, exerts beneficial effects in muscular dystrophy. The drug/prodrug system may require posology adjustment to produce wider beneficial effects on all muscle types.